Supplementary Statements On News Article

1.Date of occurrence of the event:2022/02/23 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Name of the reporting media:Economic Daily page A13, etc. 6.Content of the report: “OBI last day(Feb. 22) announced the license agreement with Odeon Therapeutics for the rights of OBI-999 and […]